Aurobindo Pharma Limited

Industry

  • Pharmaceuticals
    • Vaccines
    • Specialty Pharmaceuticals
    • OTC, Consumer
    • Generic Drugs

Other Names/Subsidiaries

  • Acrotech Biopharma
  • APL
  • Auro Vaccines
  • AuroMedics Pharma
  • AXIS Clinicals (formerly Trident Life Sciences)
  • CuraTeQ Biologics
  • GENERIS Farmacêutica
  • Glaxo (India)
  • Hyacinths Pharma
  • Longxiang Pharma Taizhou
  • Luoxin Aurovitas Pharm (Chengdu)
  • Milpharm
  • Natrol
  • Pharmacin International
  • Puren Pharma
  • Ranit Pharma
  • TL Biopharmaceutical
  • Veritaz Healthcare
See more in Biomedtracker

Latest on Aurobindo Pharma Limited

Generics Bulletin

Denosumab Race Heats Up In Europe With Eight More Nods

 
• By Dave Wallace

Four biosimilars sponsors – Biocon Biologics, Gedeon Richter, Mabxience and Zentiva – have each received dual positive opinions from the European Medicines Agency’s Committee for Medicinal Products fo

Generics Bulletin

Aurobindo Plots Rivaroxaban Roll-Out As FDA Approves 2.5mg Strength ANDA

 
• By Dean Rudge

Aurobindo plans to launch shortly its generic version of Johnson & Johnson/Bayer’s blockbuster blood thinner Xarelto (rivaroxaban) 2.5mg tablets, after receiving US Food and Drug Administration ap

Pink Sheet

Trump Tariffs: Indian Pharma Dodges Bullet, But Sword May Remain

 
• By Vibha Ravi

US President Donald Trump has announced a general 26% reciprocal tariff on India, but a country-agnostic exemption of categories like pharmaceuticals implies that Indian pharma firms will not be direc

Scrip

Mounjaro In India: Price Differential, Window Of Opportunity

 
• By Anju Ghangurde

Eli Lilly’s blockbuster obesity and type 2 diabetes therapy, Mounjaro (tirzepatide) has made its India debut throwing down the gauntlet to rival Novo Nordisk, currently in the wings with Wegovy (injec